Please note: The information displayed on this page might be outdated.
Geron Corporation: -Imetelstat is being evaluated in an ongoing Phase II trial (IMbark) in relapsed/refractory MF, and a Phase II/III trial (IMerge) in lower risk MDS.
-GERN has partnered with Janssen Biotech, Inc. to develop and commercialize imetelstat.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
USA
Clinical Stage
Phase l or ll
Disease Space
Hematology, Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Small Molecule
Website:
Address:
149 Commonwealth Drive
Menlo Park, CA 94025
United States

Company Participants at ASH - American Society of Hematology - Annual Meeting and Exposition

  • John Scarlett, M.D., President & CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.